For both sides

Does New Jersey let me sell in year one?

Federal and state law current as of September 2026 — verify with counsel.

Key takeaways

  • Generally no change of more than 50% ownership from application through two years after operations, with heir/spouse exceptions.
  • Verify with counsel.
  • State rules differ.
  • Book a call if this is a live file.

Does New Jersey let me sell in year one is the file this page underwrites. Generally no change of more than 50% ownership from application through two years after operations, with heir/spouse exceptions. Federal and state law current as of September 2026 — verify with counsel.

Direct answer to “Does New Jersey let me sell in year one?”?

Generally no change of more than 50% ownership from application through two years after operations, with heir/spouse exceptions. That is the working answer as of September 2026. It is not a guarantee of price, timing, approval, or financing.

Who should ask “Does New Jersey let me sell in year one?”?

Generally no change of more than 50% ownership from application through two years after operations, with heir/spouse exceptions. Owners, buyers, and counsel ask it at different times. HedgeStone asks it after the license class is known.

Question behind “Does New Jersey let me sell in year one?”Where to read next
Can the paper move?Transfer rules
What is cash after tax?280E
Who may own it?Eligibility
What is it worth?Valuation

A file that changes the answer to “Does New Jersey let me sell in year one?”?

Two stores with the same sales diverge because one sits under a converted-license lock and the other is clean limited paper. Does New Jersey let me sell in year one? without those facts is incomplete.

Cited sources that govern Does New Jersey let me sell in year one?: SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law. Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026. Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E.

If Does New Jersey let me sell in year one? mixes medical and adult-use, apportion. The April 2026 order is not a blended gift. Dual shops that dump all SG&A into the medical column will lose that fight with a 280E-literate CPA. Cite Federal Register 2026-08176 and IRC §280E in the same memo.

Read transfers next if that file is open on Does New Jersey let me sell in year one?. contact is the companion page when Does New Jersey let me sell in year one? needs that angle. Keep FAQ index in the working set for Does New Jersey let me sell in year one?. Read sell next if that file is open on Does New Jersey let me sell in year one?. buy is the companion page when Does New Jersey let me sell in year one? needs that angle. Keep valuation in the working set for Does New Jersey let me sell in year one?. Read federal law next if that file is open on Does New Jersey let me sell in year one?. 280E is the companion page when Does New Jersey let me sell in year one? needs that angle.

Which public sources belong on this file?

Cite USCIS Policy Manual, U.S. Treasury, DEA drug scheduling, DEA diversion schedules. A forum post is not a substitute.

How should you underwrite Does New Jersey let me sell in year one?

Does New Jersey let me sell in year one has to haircut as a license-and-tax file. In Michigan, scarcity can dominate. In Ohio, paper value can be near zero. Cited sources that govern Does New Jersey let me sell in year one: Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical.

CheckMichiganOhio
Transfer / hostVerify agencyVerify city
Tax / 280E mixMedical sliceAdult-use slice

Frequently asked questions

Does New Jersey let me sell in year one?

Generally no change of more than 50% ownership from application through two years after operations, with heir/spouse exceptions.

What capital actually funds these deals?

Seller paper, private credit, cash, or a sale-leaseback. SBA will not appear. [SAFE Banking Act of 2026, S.4942](https://www.congress.gov/bill/119th-congress/senate-bill/4942) is not a close condition for this question.

Who counts as a true party of interest?

More than the 51% owner. Silent lenders and handshake managers show up whether the CIM mentions them or not. Map them before you price this question.

Does tax debt vanish in an asset sale?

No. Cannabis tax claims can follow the buyer or the assets. Clearance certificates and holdbacks exist for this question.

Does a public listing raise the price?

Usually it raises leakage risk. Employees, landlords, and competitors learn first. Run this question as a confidential process.

What should you bring to the intro call?

License class, state, local authorization status, and whether a buyer or target is already in the room. That is enough to qualify this question.

Sources

  1. IRC §280E — https://www.law.cornell.edu/uscode/text/26/280E
  2. Viridian Capital public commentary — Tier 1 U.S. MSO EV/EBITDA ~4.16x (2025 consensus)
  3. Federal Register 2026-08176 (28 April 2026) — medical / FDA-approved marijuana to Schedule III — https://www.federalregister.gov/d/2026-08176
  4. FinCEN FIN-2014-G001 — BSA expectations for marijuana-related businesses — https://www.fincen.gov/resources/statutes-regulations/guidance/bsa-expectations-regarding-marijuana-related-businesses
  5. SBA SOP 50 10 8 (effective 1 June 2025) — marijuana ineligibility — https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs
  6. USCIS Policy Manual — https://www.uscis.gov/policy-manual
  7. U.S. Treasury — https://home.treasury.gov/
  8. DEA drug scheduling — https://www.dea.gov/drug-information/drug-scheduling